PDPL.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (21 rugp. 2023 @ 11:15):

Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc...

Stats
Šios dienos apimtis	1 063.00
Vidutinė apimtis	0.00
Rinkos kapitalizacija	101.08M
EPS	INR7.99 ( 2022-03-31 )
Last Dividend	INR1.125 ( 2010-09-13 )
Next Dividend	INR0 ( N/A )
P/E	-0.110
ATR14	INR0.0200 (0.69%)

Tūris Koreliacija

Ilgas: -0.05 (neutral)

Trumpas: 0.00 (neutral)

Signal:(33.266) Neutral

Parenteral Drugs (India) Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Parenteral Drugs (India) Koreliacija - Valiuta/Žaliavos

0.86
( strong )

0.84
( strong )

0.00
( neutral )

0.89
( strong )

-0.05
( neutral )

-0.74
( moderate negative )

Parenteral Drugs (India) Finansinės ataskaitos

Annual	2022
Pajamos:	INR84.96M
Bruto pelnas:	INR30.31M (35.67 %)
EPS:	INR-25.61

FY	2022
Pajamos:	INR84.96M
Bruto pelnas:	INR30.31M (35.67 %)
EPS:	INR-25.61

FY	2021
Pajamos:	INR121.53M
Bruto pelnas:	INR48.37M (39.80 %)
EPS:	INR-40.82

FY	2020
Pajamos:	INR240.25M
Bruto pelnas:	INR13.40M (5.58 %)
EPS:	INR-38.26

Financial Reports:

No articles found.

Parenteral Drugs (India) Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Parenteral Drugs (India) Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0.0762 - No dividend growth expected in the near future

Information

First Dividend	INR1.125	2010-09-13
Last Dividend	INR1.125	2010-09-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	1	--
Total Paid Out	INR1.125	--
Avg. Dividend % Per Year	0.00%	--
Score	0.01	--
Div. Sustainability Score	0
Div.Growth Potential Score	0.0762
Div. Directional Score	0	--

Next Divdend (Est)
(2024-04-29)

INR0 Estimate 0.00 %

Dividend Stability

0.00 Very Bad

Dividend Score

0.01

Pay Frequency

Insufficient data to determine frequency

Yearly Payout

Year	Amount	Yield
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR0	0.00%
2019	INR0	0.00%
2020	INR0	0.00%
2021	INR0	0.00%
2022	INR0	0.00%
2023	INR0	0.00%
2024	INR0	0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMLT.NS	Dividend Knight	2023-08-09	Semi-Annually	3	0.64%
MIDHANI.NS	Dividend Junior	2023-09-22	Semi-Annually	7	1.04%
HAVELLS.NS	Dividend Junior	2023-06-02	Annually	23	0.43%
BECTORFOOD.NS	Dividend Junior	2023-09-22	Semi-Annually	4	0.39%
PUNJABCHEM.NS	Dividend Junior	2023-07-27	Sporadic	18	0.16%
KENNAMET.NS	Dividend Knight	2023-05-25	Annually	4	0.76%
ELECTCAST.NS	Dividend Junior	2023-09-04	Annually	23	1.51%
AHLUCONT.NS	Dividend Junior	2023-09-22	Sporadic	15	0.04%
SUNPHARMA.NS	Dividend Junior	2023-07-28	Semi-Annually	29	0.77%
NAVA.NS	Dividend Knight	2023-07-24	Annually	23	2.35%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-8.99	1.500	-10.00	-10.00	[0 - 0.5]
returnOnAssetsTTM	-0.158	1.200	-5.26	-6.31	[0 - 0.3]
returnOnEquityTTM	0.101	1.500	9.99	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0.0559	0.800	-4.72	-3.78	[1 - 3]
quickRatioTTM	0.00970	0.800	-4.65	-3.72	[0.8 - 2.5]
cashRatioTTM	0.0000001	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0.221	-1.500	6.31	-9.47	[0 - 0.6]
interestCoverageTTM	-0.000519	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.108	[0 - 30]
freeCashFlowPerShareTTM	-0.162	2.00	-0.0809	-0.162	[0 - 20]
debtEquityRatioTTM	-0.130	-1.500	-0.520	0.781	[0 - 2.5]
grossProfitMarginTTM	0.357	1.000	7.39	7.39	[0.2 - 0.8]
operatingProfitMarginTTM	-0.00649	1.000	-2.13	-2.13	[0.1 - 0.6]
cashFlowToDebtRatioTTM	-0.00450	1.000	-1.136	-1.136	[0.2 - 2]
assetTurnoverTTM	0.0175	0.800	-3.22	-2.57	[0.5 - 2]
Total Score				-1.062

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-0.113	1.000	-0.112	0	[1 - 100]
returnOnEquityTTM	0.101	2.50	9.99	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.162	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	-0.162	2.00	-0.0540	-0.108	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	0.00111	1.500	-3.33	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	-0.0568	1.000	-3.92	0	[0.1 - 0.5]
Total Score				0.0762

Parenteral Drugs (India)

Parenteral Drugs (India) Limited operates as a healthcare company in India. The company manufactures pharmaceutical products, including intravenous infusion, inhalation, veterinary infusion, etc. It also offers IV fluids, such as carbohydrates and electrolytes, diuretics, dialysis and irrigation solutions, anti-infective and anti-fungal products, and others; and oncology and anaesthesia products. The company also exports its products to Iraq, Yemen, Mozambique, Ghana, Kenya, Kyrgyzstan, Uzbekistan, Sudan, Vietnam, Cambodia, Liberia, Sri Lanka, Nepal, Myanmar, and Cameroon. The company was incorporated in 1983 and is based in Indore, India.